Transcranial focused ultrasound to V5 enhances human visual motion brain-computer interface by modulating
Joshua Kosnoff1, Kai Yu1, Chang Liu1,2
1Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15237, USA.
Targeted neuromodulation using transcranial focused ultrasound (tFUS) significantly improved brain-computer interface (BCI) accuracy. This non-invasive technique enhances visual attention by modulating brain activity in the dorsal visual pathway.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Brain-Computer Interfaces
Background:
- Non-invasive brain-computer interfaces (BCIs) show promise for device control but suffer from high error rates.
- Neuromodulation techniques are being explored to enhance BCI performance.
- Transcranial focused ultrasound (tFUS) offers precise, non-invasive neuromodulation.
Purpose of the Study:
- To investigate if tFUS can improve BCI accuracy.
- To explore the neural mechanisms underlying tFUS effects on BCI performance using EEG source imaging.
Main Methods:
- Participants performed a BCI speller task.
- Targeted neuromodulation was applied using V5-targeted tFUS.
- High-density electroencephalography (EEG) source imaging (ESI) analyzed brain activity patterns.
Main Results:
- V5-targeted tFUS significantly reduced errors in the BCI speller task.
- EEG source imaging revealed increased theta and alpha activity in the V5 region and dorsal visual pathway under tFUS.
- Correlation analyses showed preserved dorsal pathway connectivity and weakened ventral pathway connectivity during tFUS.
Conclusions:
- V5-targeted tFUS effectively improves BCI performance by reducing errors.
- The findings suggest tFUS enhances feature-based attention to visual motion via modulation of the dorsal visual processing pathway.
More Related Videos
07:52Author Spotlight: Advancing Human Brain Modulation – Optimized Protocols for Transcranial Ultrasound Stimulation Experiments
Published on: June 28, 2024
08:37Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
Published on: December 22, 2020
